By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Predictive biology company BioSeek said today that it will collaborate with Ono Pharmaceutical in a drug target screening collaboration.

Under a three-year agreement, BioSeek will use its BioMap platform in a collaboration that will focus on a specific drug target class designated by Ono.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."